Lifevantage Corporation (LFVN)

Currency in USD
6.200
0.000(0.00%)
Real-time Data·
Advertisement
LFVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.1676.267
52 wk Range
3.90015.000
Key Statistics
Prev. Close
6.2
Open
6.2
Day's Range
6.167-6.267
52 wk Range
3.9-15
Volume
36.44K
Average Volume (3m)
481.66K
1-Year Change
-52.1974%
Book Value / Share
2.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.000
Upside
+12.90%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Lifevantage Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.000
(+12.90% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Hold---Downgrade07/05/2026
Lake Street Capital Markets
Buy5.00-19.35%12.00Maintain05/02/2026
Lake Street Capital Markets
Buy12.00+93.55%30.00Maintain05/11/2025

Lifevantage Corporation Earnings Call Summary for Q3/2026

  • LifeVantage missed Q3 FY2026 forecasts with EPS of $0.12 vs. $0.19 expected; revenue fell 25.2% YoY to $43.7M vs. $51.81M projected.
  • Stock surged 13.84% in aftermarket trading to $6.25 despite earnings miss; maintains strong balance sheet with $12.5M cash and zero debt.
  • Revenue decline driven by weak MindBody GLP-1 System sales, partially offset by LoveBiome acquisition; gross margin compressed to 79% from 81%.
  • Company guides Q4 FY2026 EPS at $0.18 and Q1 FY2027 at $0.22; plans major product launch at October 2026 convention to drive growth.
  • Analysts maintain 'Strong Buy' rating with price targets of $5-$11; FY2027 revenue forecast at $200.01M amid competitive GLP-1 market pressures.
Last Updated: 06/05/2026, 22:42
Read Full Transcript

Earnings

Latest Release
06/05/2026
EPS / Forecast
0.12 / 0.19
Revenue / Forecast
43.7M / 51.81M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.45%
Dividend Yield
3.24%
Industry Median 2.43%
Annualised payout
0.20
Paid quarterly
5-Years Growth
-
Growth Streak

Compare LFVN to Peers and Sector

Metrics to compare
LFVN
Peers
Sector
Relationship
P/E Ratio
13.6x9.4x11.6x
PEG Ratio
−0.380.310.03
Price/Book
2.3x2.1x1.5x
Price / LTM Sales
0.4x1.4x0.9x
Upside (Analyst Target)
12.9%37.4%24.7%
Fair Value Upside
Unlock38.9%14.0%Unlock

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Employees
235

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.47M11.63%9.10M
Other Institutional Investors
7.08M56.10%43.88M
Public Companies & Retail Investors
4.07M32.27%25.24M
Total
12.62M100.00%78.22M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Capital Management Corporation14.89%1,878,41111,646
Renaissance Technologies LLC6.88%867,7045,380

People Also Watch

1.695
HOVR
+7.96%
104.350
AAOI
+1.89%
8.845
RDW
+4.67%
2.33
RZLV
+0.65%
28.09
GRPN
+0.93%

FAQ

What Is the Lifevantage (NASDAQ: LFVN) Share Price Today?

The Lifevantage stock price today is 6.200 USD.

What Stock Exchange Does Lifevantage (LFVN) Trade On?

Lifevantage is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Lifevantage?

The stock symbol (also called a 'ticker') for Lifevantage is "LFVN."

Does Lifevantage Pay Dividends? What’s The Current LFVN Dividend Yield?

Yes, LFVN Pays Dividends to its Shareholders. The current Lifevantage dividend yield is 3.24%.

What Is the Current Lifevantage Market Capitalisation?

As of today, Lifevantage (NASDAQ: LFVN) market cap is 78.220M USD.

What Is Lifevantage's (LFVN) Earnings Per Share (TTM)?

The Lifevantage EPS is currently 0.451 (Trailing Twelve Months).

When Is the Next Lifevantage Earnings Date?

Lifevantage's next earnings report will be released on 25/08/2026.

Is LFVN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Lifevantage moving averages and other technical indicators, the daily buy/sell signal for LFVN stock is Sell.

How Many Times Has Lifevantage Stock Split?

Lifevantage has split 2 times. (See the LFVN stock split history page for full effective split date and price information.)

How Many Employees Does Lifevantage Have?

Lifevantage has 235 employees, based on their latest Companies House report.

What is the current trading status of Lifevantage (NASDAQ: LFVN)?

As of 20/07/2026, Lifevantage (LFVN) is trading at a share price of 6.200 USD, with a previous close of 6.200 USD. The stock has fluctuated within a day range of 6.167 USD to 6.267 USD, while its 52-week range spans from 3.900 USD to 15.000 USD.

What Is Lifevantage (LFVN) Price Target According to Analysts?

The average 12-month price target for Lifevantage is 7.000 USD, with a high estimate of 9 USD and a low estimate of 5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +12.90% Upside potential.

What Is the LFVN Premarket Price?

LFVN's last pre-market stock price is 6.150 USD. The pre-market share volume is 3,000.000, and the stock has decreased by -0.050, or -0.810%.

What Is the LFVN After Hours Price?

LFVN's last after hours stock price is 6.290 USD, the stock has decreased by 0.090, or 1.450%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.